Could a gut bacteria transplant ease a rare lung disease?

NCT ID NCT07751120

First seen Aug 07, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This early-stage trial tests whether transplanting gut bacteria from healthy donors, along with antibiotics and fiber, is safe and feasible for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. About 24 adults with PAH will be randomly assigned to receive the bacteria capsules with fiber, bacteria with a placebo, or placebos only. Researchers will track how well the donor bacteria take hold in the gut, monitor side effects, and look at early signs of impact on heart function, walking ability, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Microbiota transplant therapy (freeze-dried gut bacteria from healthy donors) with antibiotic preconditioning and fiber supplementation
What this could lead to
If successful, this could pave the way for a new gut-based treatment for pulmonary arterial hypertension, potentially improving symptoms and quality of life.
What could go wrong
This is an early, small pilot study focused on safety and feasibility, not proof of effectiveness. The transplant may not engraft or provide clinical benefit, and there are risks from antibiotics and the transplant itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Minnesota

    Minneapolis, Minnesota, 55414, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.